Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA-approved for weight management in adults with obesity or overweight with a weight-related health condition, regardless of whether diabetes is present
If you have a history of diabetic retinopathy, ischemic optic neuropathy, or other vascular conditions, talk with your doctor about whether GLP-1s are the right choice for you.' Sources: Continue reading our insights: Exploring the Psychiatric Ramifications of Weight Loss Medications Our medication management team at Philadelphia Integrative Psychiatry sometimes prescribe GLP-1 receptor agonists due to the significant weight gain associated with many psychiatric medications
Lilly Trials
On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient
Our clinical experience extends to helping patients understand the lesser-known GLP-1 benefits that may improve their health outcomes
These advancements aim to expand therapeutic options, enhance accessibility, and improve long-term adherence in the management of metabolic disorders
